[
{
"old_id":"1",
"old_nametree":"Summary Card (AFib)",
"old_numtree":"6.0.0.0",
"old_htmlpage":"null",
"new_id":"54",
"new_nametree":"Summary Card (AFib)",
"new_numtree":"1.0.0.0",
"new_htmlpage":"null"
},
{
"old_id":"2",
"old_nametree":"Overview",
"old_numtree":"1.1.0.0",
"old_htmlpage":"ENAS5189_2017070658",
"new_id":"58",
"new_nametree":"Overview",
"new_numtree":"1.1.0.0",
"new_htmlpage":"ENAS5189_2017070658"
},
{
"old_id":"3",
"old_nametree":"The 5 domains of integrated AF mgmt.",
"old_numtree":"1.2.0.0",
"old_htmlpage":"ENAS5189_2017070659",
"new_id":"59",
"new_nametree":"The 5 domains of integrated AF mgmt.",
"new_numtree":"1.2.0.0",
"new_htmlpage":"ENAS5189_2017070659"
},
{
"old_id":"4",
"old_nametree":"Diagnosis & screening",
"old_numtree":"1.3.0.0",
"old_htmlpage":"ENAS5189_2017070660",
"new_id":"60",
"new_nametree":"Diagnosis & screening",
"new_numtree":"1.3.0.0",
"new_htmlpage":"ENAS5189_2017070660"
},
{
"old_id":"5",
"old_nametree":"Prevention & general management",
"old_numtree":"1.4.0.0",
"old_htmlpage":"ENAS5189_2017070661",
"new_id":"61",
"new_nametree":"Prevention & general management",
"new_numtree":"1.4.0.0",
"new_htmlpage":"ENAS5189_2017070661"
},
{
"old_id":"6",
"old_nametree":"Patient involvement",
"old_numtree":"1.5.0.0",
"old_htmlpage":"ENAS5189_2017070662",
"new_id":"62",
"new_nametree":"Patient involvement",
"new_numtree":"1.5.0.0",
"new_htmlpage":"ENAS5189_2017070662"
},
{
"old_id":"7",
"old_nametree":"Stroke prevention",
"old_numtree":"1.6.0.0",
"old_htmlpage":"ENAS5189_2017070663",
"new_id":"63",
"new_nametree":"Stroke prevention",
"new_numtree":"1.6.0.0",
"new_htmlpage":"ENAS5189_2017070663"
},
{
"old_id":"8",
"old_nametree":"Risk factors",
"old_numtree":"1.7.0.0",
"old_htmlpage":"ENAS5189_2017070664",
"new_id":"64",
"new_nametree":"Risk factors",
"new_numtree":"1.7.0.0",
"new_htmlpage":"ENAS5189_2017070664"
},
{
"old_id":"9",
"old_nametree":"Stroke prevention in atrial fibrillation",
"old_numtree":"1.8.0.0",
"old_htmlpage":"ENAS5189_2017070665",
"new_id":"65",
"new_nametree":"Stroke prevention in atrial fibrillation",
"new_numtree":"1.8.0.0",
"new_htmlpage":"ENAS5189_2017070665"
},
{
"old_id":"10",
"old_nametree":"Heart rate control",
"old_numtree":"1.9.0.0",
"old_htmlpage":"ENAS5189_2017070666",
"new_id":"66",
"new_nametree":"Heart rate control",
"new_numtree":"1.9.0.0",
"new_htmlpage":"ENAS5189_2017070666"
},
{
"old_id":"11",
"old_nametree":"Rhythm control",
"old_numtree":"1.10.0.0",
"old_htmlpage":"ENAS5189_2017070667",
"new_id":"67",
"new_nametree":"Rhythm control",
"new_numtree":"1.10.0.0",
"new_htmlpage":"ENAS5189_2017070667"
},
{
"old_id":"12",
"old_nametree":"Integrated care of AF patients",
"old_numtree":"1.11.0.0",
"old_htmlpage":"ENAS5189_2017070668",
"new_id":"68",
"new_nametree":"Integrated care of AF patients",
"new_numtree":"1.11.0.0",
"new_htmlpage":"ENAS5189_2017070668"
},
{
"old_id":"13",
"old_nametree":"Clinical signs for urgent AF referral",
"old_numtree":"1.12.0.0",
"old_htmlpage":"ENAS5189_2017070669",
"new_id":"69",
"new_nametree":"Clinical signs for urgent AF referral",
"new_numtree":"1.12.0.0",
"new_htmlpage":"ENAS5189_2017070669"
},
{
"old_id":"14",
"old_nametree":"Summary Card (HF)",
"old_numtree":"7.0.0.0",
"old_htmlpage":"null",
"new_id":"55",
"new_nametree":"Summary Card (HF)",
"new_numtree":"2.0.0.0",
"new_htmlpage":"null"
},
{
"old_id":"15",
"old_nametree":"Overview",
"old_numtree":"2.1.0.0",
"old_htmlpage":"ENAS5189_2017070670",
"new_id":"70",
"new_nametree":"Overview",
"new_numtree":"2.1.0.0",
"new_htmlpage":"ENAS5189_2017070670"
},
{
"old_id":"16",
"old_nametree":"Definition",
"old_numtree":"2.2.0.0",
"old_htmlpage":"ENAS5189_2017070671",
"new_id":"71",
"new_nametree":"Definition",
"new_numtree":"2.2.0.0",
"new_htmlpage":"ENAS5189_2017070671"
},
{
"old_id":"17",
"old_nametree":"Diagnosis of HF (non-acute onset)",
"old_numtree":"2.3.0.0",
"old_htmlpage":"ENAS5189_2017070672",
"new_id":"72",
"new_nametree":"Diagnosis of HF (non-acute onset)",
"new_numtree":"2.3.0.0",
"new_htmlpage":"ENAS5189_2017070672"
},
{
"old_id":"18",
"old_nametree":"Therapeutic algo. for symptomatic HFrEF",
"old_numtree":"2.4.0.0",
"old_htmlpage":"ENAS5189_2017070673",
"new_id":"73",
"new_nametree":"Therapeutic algo. for symptomatic HFrEF",
"new_numtree":"2.4.0.0",
"new_htmlpage":"ENAS5189_2017070673"
},
{
"old_id":"19",
"old_nametree":"Initial mgmt. of a patient with AHF",
"old_numtree":"2.5.0.0",
"old_htmlpage":"ENAS5189_2017070674",
"new_id":"74",
"new_nametree":"Initial mgmt. of a patient with AHF",
"new_numtree":"2.5.0.0",
"new_htmlpage":"ENAS5189_2017070674"
},
{
"old_id":"20",
"old_nametree":"Mgmt. of AHF based on clinical profile",
"old_numtree":"2.6.0.0",
"old_htmlpage":"ENAS5189_2017070675",
"new_id":"75",
"new_nametree":"Mgmt. of AHF based on clinical profile",
"new_numtree":"2.6.0.0",
"new_htmlpage":"ENAS5189_2017070675"
},
{
"old_id":"21",
"old_nametree":"ICD and CRT indication",
"old_numtree":"2.7.0.0",
"old_htmlpage":"ENAS5189_2017070676",
"new_id":"76",
"new_nametree":"ICD and CRT indication",
"new_numtree":"2.7.0.0",
"new_htmlpage":"ENAS5189_2017070676"
},
{
"old_id":"22",
"old_nametree":"LVAD eligible patients",
"old_numtree":"2.8.0.0",
"old_htmlpage":"ENAS5189_2017070677",
"new_id":"77",
"new_nametree":"LVAD eligible patients",
"new_numtree":"2.8.0.0",
"new_htmlpage":"ENAS5189_2017070677"
},
{
"old_id":"23",
"old_nametree":"Charact. & components of mgmt. programmes",
"old_numtree":"2.9.0.0",
"old_htmlpage":"ENAS5189_2017070678",
"new_id":"78",
"new_nametree":"Charact. & components of mgmt. programmes",
"new_numtree":"2.9.0.0",
"new_htmlpage":"ENAS5189_2017070678"
},
{
"old_id":"24",
"old_nametree":"Palliative care service in HF",
"old_numtree":"2.10.0.0",
"old_htmlpage":"ENAS5189_2017070679",
"new_id":"79",
"new_nametree":"Palliative care service in HF",
"new_numtree":"2.10.0.0",
"new_htmlpage":"ENAS5189_2017070679"
},
{
"old_id":"25",
"old_nametree":"Summary Card (CVD Prev)",
"old_numtree":"8.0.0.0",
"old_htmlpage":"null",
"new_id":"56",
"new_nametree":"Summary Card (CVD Prev)",
"new_numtree":"3.0.0.0",
"new_htmlpage":"null"
},
{
"old_id":"26",
"old_nametree":"Definition of CVD prevention",
"old_numtree":"3.1.0.0",
"old_htmlpage":"ENAS5189_2017070680",
"new_id":"80",
"new_nametree":"Definition of CVD prevention",
"new_numtree":"3.1.0.0",
"new_htmlpage":"ENAS5189_2017070680"
},
{
"old_id":"27",
"old_nametree":"Relevance of CVD prevention in practice",
"old_numtree":"3.2.0.0",
"old_htmlpage":"ENAS5189_2017070681",
"new_id":"81",
"new_nametree":"Relevance of CVD prevention in practice",
"new_numtree":"3.2.0.0",
"new_htmlpage":"ENAS5189_2017070681"
},
{
"old_id":"28",
"old_nametree":"Who will benefit from prevention?",
"old_numtree":"3.3.0.0",
"old_htmlpage":"ENAS5189_2017070682",
"new_id":"82",
"new_nametree":"Who will benefit from prevention?",
"new_numtree":"3.3.0.0",
"new_htmlpage":"ENAS5189_2017070682"
},
{
"old_id":"29",
"old_nametree":"How to estimate total CV risk?",
"old_numtree":"3.4.0.0",
"old_htmlpage":"ENAS5189_2017070683",
"new_id":"83",
"new_nametree":"How to estimate total CV risk?",
"new_numtree":"3.4.0.0",
"new_htmlpage":"ENAS5189_2017070683"
},
{
"old_id":"30",
"old_nametree":"How to use the risk estimation charts",
"old_numtree":"3.5.0.0",
"old_htmlpage":"ENAS5189_2017070684",
"new_id":"84",
"new_nametree":"How to use the risk estimation charts",
"new_numtree":"3.5.0.0",
"new_htmlpage":"ENAS5189_2017070684"
},
{
"old_id":"31",
"old_nametree":"SCORE chart for HIGH-risk countries",
"old_numtree":"3.6.0.0",
"old_htmlpage":"ENAS5189_2017070685",
"new_id":"85",
"new_nametree":"SCORE chart for HIGH-risk countries",
"new_numtree":"3.6.0.0",
"new_htmlpage":"ENAS5189_2017070685"
},
{
"old_id":"32",
"old_nametree":"SCORE chart for LOW-risk countries",
"old_numtree":"3.7.0.0",
"old_htmlpage":"ENAS5189_2017070686",
"new_id":"86",
"new_nametree":"SCORE chart for LOW-risk countries",
"new_numtree":"3.7.0.0",
"new_htmlpage":"ENAS5189_2017070686"
},
{
"old_id":"33",
"old_nametree":"Risk categories: priorities",
"old_numtree":"3.8.0.0",
"old_htmlpage":"ENAS5189_2017070687",
"new_id":"87",
"new_nametree":"Risk categories: priorities",
"new_numtree":"3.8.0.0",
"new_htmlpage":"ENAS5189_2017070687"
},
{
"old_id":"34",
"old_nametree":"Main targets and goals",
"old_numtree":"3.9.0.0",
"old_htmlpage":"ENAS5189_2017070688",
"new_id":"88",
"new_nametree":"Main targets and goals",
"new_numtree":"3.9.0.0",
"new_htmlpage":"ENAS5189_2017070688"
},
{
"old_id":"35",
"old_nametree":"Summary Card (Cardio-Onco)",
"old_numtree":"9.0.0.0",
"old_htmlpage":"null",
"new_id":"57",
"new_nametree":"Summary Card (Cardio-Onco)",
"new_numtree":"4.0.0.0",
"new_htmlpage":"null"
},
{
"old_id":"36",
"old_nametree":"Myocardial dysfunction and heart failure",
"old_numtree":"4.1.0.0",
"old_htmlpage":"ENAS5189_2017070689",
"new_id":"89",
"new_nametree":"Myocardial dysfunction and heart failure",
"new_numtree":"4.1.0.0",
"new_htmlpage":"ENAS5189_2017070689"
},
{
"old_id":"37",
"old_nametree":"Baseline risk factors for cardiotoxicity",
"old_numtree":"4.2.0.0",
"old_htmlpage":"ENAS5189_2017070690",
"new_id":"90",
"new_nametree":"Baseline risk factors for cardiotoxicity",
"new_numtree":"4.2.0.0",
"new_htmlpage":"ENAS5189_2017070690"
},
{
"old_id":"38",
"old_nametree":"Key points",
"old_numtree":"4.3.0.0",
"old_htmlpage":"ENAS5189_2017070691",
"new_id":"91",
"new_nametree":"Key points",
"new_numtree":"4.3.0.0",
"new_htmlpage":"ENAS5189_2017070691"
},
{
"old_id":"39",
"old_nametree":"Coronary artery disease",
"old_numtree":"4.4.0.0",
"old_htmlpage":"ENAS5189_2017070692",
"new_id":"92",
"new_nametree":"Coronary artery disease",
"new_numtree":"4.4.0.0",
"new_htmlpage":"ENAS5189_2017070692"
},
{
"old_id":"40",
"old_nametree":"Arrhythmias",
"old_numtree":"4.5.0.0",
"old_htmlpage":"ENAS5189_2017070693",
"new_id":"93",
"new_nametree":"Arrhythmias",
"new_numtree":"4.5.0.0",
"new_htmlpage":"ENAS5189_2017070693"
},
{
"old_id":"41",
"old_nametree":"QT prolongation",
"old_numtree":"4.6.0.0",
"old_htmlpage":"ENAS5189_2017070694",
"new_id":"94",
"new_nametree":"QT prolongation",
"new_numtree":"4.6.0.0",
"new_htmlpage":"ENAS5189_2017070694"
},
{
"old_id":"42",
"old_nametree":"Atrial fibrillation",
"old_numtree":"4.7.0.0",
"old_htmlpage":"ENAS5189_2017070695",
"new_id":"95",
"new_nametree":"Atrial fibrillation",
"new_numtree":"4.7.0.0",
"new_htmlpage":"ENAS5189_2017070695"
},
{
"old_id":"43",
"old_nametree":"Thromboembolic disease",
"old_numtree":"4.8.0.0",
"old_htmlpage":"ENAS5189_2017070696",
"new_id":"96",
"new_nametree":"Thromboembolic disease",
"new_numtree":"4.8.0.0",
"new_htmlpage":"ENAS5189_2017070696"
},
{
"old_id":"44",
"old_nametree":"Prevention of cardiotoxicity",
"old_numtree":"4.9.0.0",
"old_htmlpage":"ENAS5189_2017070697",
"new_id":"97",
"new_nametree":"Prevention of cardiotoxicity",
"new_numtree":"4.9.0.0",
"new_htmlpage":"ENAS5189_2017070697"
},
{
"old_id":"45",
"old_nametree":"Summary Card (DM)",
"old_numtree":"1.0.0.0",
"old_htmlpage":"null",
"new_id":"1",
"new_nametree":"Summary Card (DM)",
"new_numtree":"5.0.0.0",
"new_htmlpage":"null"
},
{
"old_id":"46",
"old_nametree":"Overview",
"old_numtree":"1.1.0.0",
"old_htmlpage":"ENAS5189_1.1.0.0",
"new_id":"2",
"new_nametree":"Overview",
"new_numtree":"5.1.0.0",
"new_htmlpage":"ENAS5189_1.1.0.0"
},
{
"old_id":"47",
"old_nametree":"Identify. pat. W DM & at risk for dev. DM",
"old_numtree":"1.2.0.0",
"old_htmlpage":"ENAS5189_1.2.0.0",
"new_id":"3",
"new_nametree":"Identify. pat. W DM & at risk for dev. DM",
"new_numtree":"5.2.0.0",
"new_htmlpage":"ENAS5189_1.2.0.0"
},
{
"old_id":"48",
"old_nametree":"CV risk assess. in pat. with dysglycaemia",
"old_numtree":"1.3.0.0",
"old_htmlpage":"ENAS5189_1.3.0.0",
"new_id":"4",
"new_nametree":"CV risk assess. in pat. with dysglycaemia",
"new_numtree":"5.3.0.0",
"new_htmlpage":"ENAS5189_1.3.0.0"
},
{
"old_id":"49",
"old_nametree":"Recs. on lstyle modif. in diabetes",
"old_numtree":"1.4.0.0",
"old_htmlpage":"ENAS5189_1.4.0.0",
"new_id":"5",
"new_nametree":"Recs. on lstyle modif. in diabetes",
"new_numtree":"5.4.0.0",
"new_htmlpage":"ENAS5189_1.4.0.0"
},
{
"old_id":"50",
"old_nametree":"Prevention of diabetes in patients with IGT",
"old_numtree":"1.5.0.0",
"old_htmlpage":"ENAS5189_1.5.0.0",
"new_id":"6",
"new_nametree":"Prevention of diabetes in patients with IGT",
"new_numtree":"5.5.0.0",
"new_htmlpage":"ENAS5189_1.5.0.0"
},
{
"old_id":"51",
"old_nametree":"Recommendations for patient with DM & CVD",
"old_numtree":"1.6.0.0",
"old_htmlpage":"ENAS5189_1.6.0.0",
"new_id":"7",
"new_nametree":"Recommendations for patient with DM & CVD",
"new_numtree":"5.6.0.0",
"new_htmlpage":"ENAS5189_1.6.0.0"
},
{
"old_id":"52",
"old_nametree":"Glucose and other risk factor control",
"old_numtree":"1.7.0.0",
"old_htmlpage":"ENAS5189_1.7.0.0",
"new_id":"8",
"new_nametree":"Glucose and other risk factor control",
"new_numtree":"5.7.0.0",
"new_htmlpage":"ENAS5189_1.7.0.0"
},
{
"old_id":"53",
"old_nametree":"Microvascular complications",
"old_numtree":"1.8.0.0",
"old_htmlpage":"ENAS5189_1.8.0.0",
"new_id":"9",
"new_nametree":"Microvascular complications",
"new_numtree":"5.8.0.0",
"new_htmlpage":"ENAS5189_1.8.0.0"
},
{
"old_id":"54",
"old_nametree":"Patient-centred care in DM & CVD",
"old_numtree":"1.9.0.0",
"old_htmlpage":"ENAS5189_1.9.0.0",
"new_id":"10",
"new_nametree":"Patient-centred care in DM & CVD",
"new_numtree":"5.9.0.0",
"new_htmlpage":"ENAS5189_1.9.0.0"
},
{
"old_id":"55",
"old_nametree":"Summary Card (HCM)",
"old_numtree":"2.0.0.0",
"old_htmlpage":"null",
"new_id":"11",
"new_nametree":"Summary Card (HCM)",
"new_numtree":"6.0.0.0",
"new_htmlpage":"null"
},
{
"old_id":"56",
"old_nametree":"Definition",
"old_numtree":"2.1.0.0",
"old_htmlpage":"ENAS5189_2.1.0.0",
"new_id":"12",
"new_nametree":"Definition",
"new_numtree":"6.1.0.0",
"new_htmlpage":"ENAS5189_2.1.0.0"
},
{
"old_id":"57",
"old_nametree":"Aetiology",
"old_numtree":"2.2.0.0",
"old_htmlpage":"ENAS5189_2.2.0.0",
"new_id":"13",
"new_nametree":"Aetiology",
"new_numtree":"6.2.0.0",
"new_htmlpage":"ENAS5189_2.2.0.0"
},
{
"old_id":"58",
"old_nametree":"Clinical presentation",
"old_numtree":"2.3.0.0",
"old_htmlpage":"ENAS5189_2.3.0.0",
"new_id":"14",
"new_nametree":"Clinical presentation",
"new_numtree":"6.3.0.0",
"new_htmlpage":"ENAS5189_2.3.0.0"
},
{
"old_id":"59",
"old_nametree":"Tests in pat. W definite or suspected HCM",
"old_numtree":"2.4.0.0",
"old_htmlpage":"ENAS5189_2.4.0.0",
"new_id":"15",
"new_nametree":"Tests in pat. W definite or suspected HCM",
"new_numtree":"6.4.0.0",
"new_htmlpage":"ENAS5189_2.4.0.0"
},
{
"old_id":"60",
"old_nametree":"Genetic counselling and testing",
"old_numtree":"2.5.0.0",
"old_htmlpage":"ENAS5189_2.5.0.0",
"new_id":"16",
"new_nametree":"Genetic counselling and testing",
"new_numtree":"6.5.0.0",
"new_htmlpage":"ENAS5189_2.5.0.0"
},
{
"old_id":"61",
"old_nametree":"Mgmt. & prevention of imp. complications",
"old_numtree":"2.6.0.0",
"old_htmlpage":"ENAS5189_2.6.0.0",
"new_id":"17",
"new_nametree":"Mgmt. & prevention of imp. complications",
"new_numtree":"6.6.0.0",
"new_htmlpage":"ENAS5189_2.6.0.0"
},
{
"old_id":"62",
"old_nametree":"Mgmt. of LV outflow tract obstruction",
"old_numtree":"2.7.0.0",
"old_htmlpage":"ENAS5189_2.7.0.0",
"new_id":"18",
"new_nametree":"Mgmt. of LV outflow tract obstruction",
"new_numtree":"6.7.0.0",
"new_htmlpage":"ENAS5189_2.7.0.0"
},
{
"old_id":"63",
"old_nametree":"Management of heart failure symptoms",
"old_numtree":"2.8.0.0",
"old_htmlpage":"ENAS5189_2.8.0.0",
"new_id":"19",
"new_nametree":"Management of heart failure symptoms",
"new_numtree":"6.8.0.0",
"new_htmlpage":"ENAS5189_2.8.0.0"
},
{
"old_id":"64",
"old_nametree":"Management of atrial tachyarrhythmia",
"old_numtree":"2.9.0.0",
"old_htmlpage":"ENAS5189_2.9.0.0",
"new_id":"20",
"new_nametree":"Management of atrial tachyarrhythmia",
"new_numtree":"6.9.0.0",
"new_htmlpage":"ENAS5189_2.9.0.0"
},
{
"old_id":"65",
"old_nametree":"Sudden death prevention",
"old_numtree":"2.10.0.0",
"old_htmlpage":"ENAS5189_2.10.0.0",
"new_id":"21",
"new_nametree":"Sudden death prevention",
"new_numtree":"6.10.0.0",
"new_htmlpage":"ENAS5189_2.10.0.0"
},
{
"old_id":"66",
"old_nametree":"Routine follow-up",
"old_numtree":"2.11.0.0",
"old_htmlpage":"ENAS5189_2.11.0.0",
"new_id":"22",
"new_nametree":"Routine follow-up",
"new_numtree":"6.11.0.0",
"new_htmlpage":"ENAS5189_2.11.0.0"
},
{
"old_id":"67",
"old_nametree":"General lifestyle considerations",
"old_numtree":"2.12.0.0",
"old_htmlpage":"ENAS5189_2.12.0.0",
"new_id":"23",
"new_nametree":"General lifestyle considerations",
"new_numtree":"6.12.0.0",
"new_htmlpage":"ENAS5189_2.12.0.0"
},
{
"old_id":"68",
"old_nametree":"Summary Card (Pacing)",
"old_numtree":"4.0.0.0",
"old_htmlpage":"null",
"new_id":"33",
"new_nametree":"Summary Card (Pacing)",
"new_numtree":"7.0.0.0",
"new_htmlpage":"null"
},
{
"old_id":"69",
"old_nametree":"Overview",
"old_numtree":"4.1.0.0",
"old_htmlpage":"ENAS5189_4.1.0.0",
"new_id":"34",
"new_nametree":"Overview",
"new_numtree":"7.1.0.0",
"new_htmlpage":"ENAS5189_4.1.0.0"
},
{
"old_id":"70",
"old_nametree":"Patients with persistent bradycardia",
"old_numtree":"4.2.0.0",
"old_htmlpage":"ENAS5189_4.2.0.0",
"new_id":"35",
"new_nametree":"Patients with persistent bradycardia",
"new_numtree":"7.2.0.0",
"new_htmlpage":"ENAS5189_4.2.0.0"
},
{
"old_id":"71",
"old_nametree":"Patients with intermit. document. bradycardia",
"old_numtree":"4.3.0.0",
"old_htmlpage":"ENAS5189_4.3.0.0",
"new_id":"36",
"new_nametree":"Patients with intermit. document. bradycardia",
"new_numtree":"7.3.0.0",
"new_htmlpage":"ENAS5189_4.3.0.0"
},
{
"old_id":"72",
"old_nametree":"Pats. with syncope and suspected bradycardia",
"old_numtree":"4.4.0.0",
"old_htmlpage":"ENAS5189_4.4.0.0",
"new_id":"37",
"new_nametree":"Pats. with syncope and suspected bradycardia",
"new_numtree":"7.4.0.0",
"new_htmlpage":"ENAS5189_4.4.0.0"
},
{
"old_id":"73",
"old_nametree":"Indications for CRT in pat. with HF or low EF",
"old_numtree":"4.5.0.0",
"old_htmlpage":"ENAS5189_4.5.0.0",
"new_id":"38",
"new_nametree":"Indications for CRT in pat. with HF or low EF",
"new_numtree":"7.5.0.0",
"new_htmlpage":"ENAS5189_4.5.0.0"
},
{
"old_id":"74",
"old_nametree":"Key evidence supporting recs.",
"old_numtree":"4.6.0.0",
"old_htmlpage":"ENAS5189_4.6.0.0",
"new_id":"39",
"new_nametree":"Key evidence supporting recs.",
"new_numtree":"7.6.0.0",
"new_htmlpage":"ENAS5189_4.6.0.0"
},
{
"old_id":"75",
"old_nametree":"CRT indi. in Pat. W HF & low EF in sinus rhythm",
"old_numtree":"4.7.0.0",
"old_htmlpage":"ENAS5189_4.7.0.0",
"new_id":"40",
"new_nametree":"CRT indi. in Pat. W HF & low EF in sinus rhythm",
"new_numtree":"7.7.0.0",
"new_htmlpage":"ENAS5189_4.7.0.0"
},
{
"old_id":"76",
"old_nametree":"Indications for CRT in patients in AF",
"old_numtree":"4.8.0.0",
"old_htmlpage":"ENAS5189_4.8.0.0",
"new_id":"41",
"new_nametree":"Indications for CRT in patients in AF",
"new_numtree":"7.8.0.0",
"new_htmlpage":"ENAS5189_4.8.0.0"
},
{
"old_id":"77",
"old_nametree":"Indi. for upgraded or “de novo” CRT",
"old_numtree":"4.9.0.0",
"old_htmlpage":"ENAS5189_4.9.0.0",
"new_id":"42",
"new_nametree":"Indi. for upgraded or “de novo” CRT",
"new_numtree":"7.9.0.0",
"new_htmlpage":"ENAS5189_4.9.0.0"
},
{
"old_id":"78",
"old_nametree":"Choice of CRT-P or CRT-D in prim. prevention",
"old_numtree":"4.10.0.0",
"old_htmlpage":"ENAS5189_4.10.0.0",
"new_id":"43",
"new_nametree":"Choice of CRT-P or CRT-D in prim. prevention",
"new_numtree":"7.10.0.0",
"new_htmlpage":"ENAS5189_4.10.0.0"
}
]